Product
CMOP±R
1 clinical trial
1 indication
Indication
Non-Hodgkin lymphomaClinical trial
A Single-arm, Multi-center, Prospective Clinical Study of Mitoxantrone Hydrochloride Liposome Injection-based CMOP±R Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's LymphomaStatus: Not yet recruiting, Estimated PCD: 2025-08-31